Mark M. Blatter

6.0k citations

84 papers · 4.2k indexed · 1 hit paper · h-index 32

Microbiology top 0.2%
- Bacterial Infections and Vaccines 35
Epidemiology top 0.5%
- Pneumonia and Respiratory Infections 34
- Influenza Virus Research Studies 20
- Respiratory viral infections research 19
- Hepatitis B Virus Studies 13
- Virology and Viral Diseases 9
Otorhinolaryngology top 1%
Health top 2%
- Vaccine Coverage and Hesitancy 9
Infectious Diseases top 5%
Nutrition and Dietetics
- Infant Nutrition and Health 9

Co-authors: Keith S. Reisinger Gary Dubin Anne Schuind Newton Sérgio de Carvalho Cecília Roteli-Martins Paulo Naud Bruce L. Innis Júlio César Teixeira
Cited by: Microbiology Epidemiology Otorhinolaryngology
Journals: The Pediatric Infectious Disease Journal (25 papers)PEDIATRICS (12 papers)Vaccine (10 papers)
Partner nations: United States Belgium United Kingdom

In The Last Decade

Mark M. Blatter

84 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Mark M. Blatter

Since Specialization

Citations

This map shows the geographic impact of Mark M. Blatter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Blatter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Blatter more than expected).

Fields of papers citing papers by Mark M. Blatter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Blatter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Blatter. The network helps show where Mark M. Blatter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark M. Blatter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark M. Blatter Line = papers co-authored together Mark M. Blatter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial BMJ Open ·Agnihotram V. Ramanakumar,Paulo Naud,Cecília Roteli-Martins,Newton Sérgio de Carvalho,Paola Colares de Borba,Júlio César Teixeira,Mark M. Blatter,Anna‐Barbara Moscicki,Diane M. Harper,Barbara Romanowski,Stephen K. Tyring,Brian Ramjattan,Anne Schuind,Gary Dubin,Eduardo L. Franco	2016	27
2	Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae–N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy Vaccine ·Ia. S. Bugrov,G Ebenbichler,J. Hewitt,Rainer Bertzbach,Hua Qing,Luthfiardi,Paul Matthäi,Mark M. Blatter,Véronique Bianco,Yaela Baine,Leonard R. Friedland,Jacqueline M. Miller	2014	6
3	Milk Protein–Based Infant Formula Containing Rice Starch and Low Lactose Reduces Common Regurgitation in Healthy Term Infants: A Randomized, Blinded, and Prospective Trial Journal of the American College of Nutrition ·John B. Lasekan,道彦森,Jeffery Oliver,Jane D. Carver,Mark M. Blatter,Matthew J. Kuchan,A.V. Anandaswaroop,Paul F. Pollack	2014	12
4	Immunogenicity and Safety of Two Tetravalent (Measles, Mumps, Rubella, Varicella) Vaccines Coadministered With Hepatitis A and Pneumococcal Conjugate Vaccines to Children Twelve to Fourteen Months of Age The Pediatric Infectious Disease Journal ·Mark M. Blatter,Nicola P. Klein,Linlin Cao,Ia. S. Bugrov,M. Gruters,Martin Schear,Maurice A. Mufson,Judith M. Martin,Meera Varman,Sang Ug,Eunbi Koh,Amatelrauf Tawfik Ghanem,Martine Douha,Ouzama Nicholson,Christopher da Costa,Bruce L. Innis	2012	20
5	Prevalence of Human Papillomavirus Infection and Associated Risk Factors in Young Women in Brazil, Canada, and the United States International Journal of Gynecological Pathology ·Cecília Roteli-Martins,Newton Sérgio de Carvalho,Paulo Naud,Júlio César Teixeira,Paola Colares de Borba,Sophie Derchain,Stephen K. Tyring,Stanley A. Gall,Gao Qinghao,Mark M. Blatter,R. Michael Shier,Barbara Romanowski,Wim Quint,妙子木内,Claudia Martins Galindo,Anne Schuind,Gary Dubin	2011	29
6	Influenza A (H1N1) 2009 two-dose immunization of US children: An observer-blinded, randomized, placebo-controlled trial Vaccine ·Eric Plennevaux,Mark M. Blatter,正宏永澤,Grigory Feliksovich Tselniker,Daniel Kirby,Duane Johnston,Reverend Robert M. Brodie,Martine Denis	2011	30
7	Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants The Pediatric Infectious Disease Journal ·Janet A. Englund,Emmanuel B. Walter,Steven Black,Mark M. Blatter,T. Nkaoua,Frederick L. Ruben,Michael D. Decker	2010	34
8	IMMUNE RESPONSE AND ONE-YEAR ANTIBODY PERSISTENCE AFTER A FOURTH DOSE OF A NOVEL HAEMOPHILUS INFLUENZAE TYPE B AND NEISSERIA MENINGITIDIS SEROGROUPS C AND Y-TETANUS TOXOID CONJUGATE VACCINE (HibMenCY) AT 12 TO 15 MONTHS OF AGE The Pediatric Infectious Disease Journal ·Gary S. Marshall,Colin D. Marchant,Mark M. Blatter,Emmanuel Aris,Dominique Boutriau,Jan Poolman,Leonard R. Friedland,Jacqueline M. Miller	2010	17
9	Rapid and Sustained Immune Response Against Hepatitis A and B Achieved With Combined Vaccine Using an Accelerated Administration Schedule Journal of Travel Medicine ·Bradley A. Connor,Mark M. Blatter,Jiřı́ Beran,Bin Zou,Andrew F. Trofa	2007	22
10	Immunogenicity and Safety of a Combination Diphtheria, Tetanus Toxoid, Acellular Pertussis, Hepatitis B, and Inactivated Poliovirus Vaccine Coadministered with a 7-Valent Pneumococcal Conjugate Vaccine and a Haemophilus Influenzae Type b Conjugate Vaccine The Journal of Pediatrics ·Michael E. Pichichero,Henry H. Bernstein,Mark M. Blatter,Lode Schuerman,Brigitte Cheuvart,Sandra J. Holmes	2007	25
11	Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized, Controlled Trial Obstetrical & Gynecological Survey ·Diane M. Harper,Eduardo L. Franco,Cosette M. Wheeler,Daron G. Ferris,David Jenkins,Anne Schuind,Toufik Zahaf,Bruce L. Innis,Paulo Naud,Newton Sérgio de Carvalho,Cecília Roteli-Martins,Marcos Flávio Portela Veras,Mark M. Blatter,冯勉,Wim Quint,Gary Dubin	2005	12
12	Comparative Trial of the Safety and Immunogenicity of Quadrivalent (A, C, Y, W-135) Meningococcal Polysaccharide-Diphtheria Conjugate Vaccine Versus Quadrivalent Polysaccharide Vaccine in Two- to Ten-Year-Old Children The Pediatric Infectious Disease Journal ·Michael E. Pichichero,Janet R. Casey,Mark M. Blatter,Edward Rothstein,Robert Ryall,Allagulyyeva A.,Gregory Gilmet,Thomas Papa	2005	82
13	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialbreakdown → The Lancet ·Diane M. Harper,Eduardo L. Franco,Cosette M. Wheeler,Daron G. Ferris,David Jenkins,Anne Schuind,Toufik Zahaf,Bruce L. Innis,Paulo Naud,Newton Sérgio de Carvalho,Cecília Roteli-Martins,Júlio César Teixeira,Mark M. Blatter,Abner Korn,Wim Quint,Gary Dubin	2004	1188
14	Immune Status of Infants Fed Soy‐Based Formulas With or Without Added Nucleotides for 1 Year: Part 2: Immune Cell Populations Journal of Pediatric Gastroenterology and Nutrition ·Christopher T. Cordle,Timothy R. Winship,Joseph P. Schaller,Debra Thomas,Rachael H. Buck,Karin M. Ostrom,Joan R. Jacobs,Mark M. Blatter,Sechin Cho,Willis M. Gooch,Larry K. Pickering	2002	3
15	Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination The Pediatric Infectious Disease Journal ·Michael E. Pichichero,Mark M. Blatter,Keith S. Reisinger,Christopher J. Harrison,Candice E. Johnson,Mark C. Steinhoff,Shelly Senders,Edward Rothstein,Paul Willems,Barbara J. Howe	2002	41
16	An acellular pertussis vaccine in healthy adults: safety and immunogenicity Vaccine ·Edward Rothstein,Edwin L. Anderson,Michael D. Decker,Gregory A. Poland,Keith S. Reisinger,Mark M. Blatter,Robert M. Jacobson,ChrisAnna M. Mink,Daniel Gennevois,Allen Izu,Faruk Sinangil,Andria Langenberg	1999	22
17	Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine The Pediatric Infectious Disease Journal ·Neal A. Halsey,Mark M. Blatter,دليلة بوزغار,M. L. Thoms,Field F. Willingham,Miriam Díaz Granado,Tihomir Staykov,D Y.-M.,Keith S. Reisinger,大樹江藤	1997	24
18	Comparative study of sultamicilln and amoxicillin-clavulanate The Pediatric Infectious Disease Journal ·Kenny H. Chan,Charles D. Bluestone,Wasiyanto Wasiyanto,Abdwar Hernán Ortiz Damián,Mark M. Blatter,Patricia A. Fall	1993	18
19	Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17− to 24-month-old children The Pediatric Infectious Disease Journal ·Mary P. Glodé,Raphael E i. Liesegang,Keith S. Reisinger,Mark M. Blatter,八郎大戸國,Barbara Watson,Teddy Arga Saputro,Basim I. Asmar,Michael J. Berry,Karri Silventoinen,永木耕介,Jill Hackell,夏樹羽柴,Patricia Hanik	1992	22
20	Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children The Pediatric Infectious Disease Journal ·Margaret A. Kenna,Charles D. Bluestone,Patricia A. Fall,Т. С. Гудіма,Marcia Kurs‐Lasky,Amitav Sarma,Mark M. Blatter,Keith S. Reisinger	1987	34

About Mark M. Blatter

Mark M. Blatter is a scholar working on Microbiology, Epidemiology and Otorhinolaryngology, having authored 84 papers that have together received 4.2k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (35 papers), Pneumonia and Respiratory Infections (34 papers), Influenza Virus Research Studies (20 papers), Respiratory viral infections research (19 papers), Hepatitis B Virus Studies (13 papers), Virology and Viral Diseases (9 papers), Infant Nutrition and Health (9 papers) and Vaccine Coverage and Hesitancy (9 papers). The work is most often cited by research in Microbiology (925 citations), Epidemiology (3.1k citations) and Otorhinolaryngology (373 citations). Mark M. Blatter has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Keith S. Reisinger, Gary Dubin, Anne Schuind, Newton Sérgio de Carvalho, Cecília Roteli-Martins, Paulo Naud, Bruce L. Innis, Júlio César Teixeira, Cosette M. Wheeler and Eduardo L. Franco. Their work appears in journals such as The Pediatric Infectious Disease Journal, PEDIATRICS, Vaccine, Journal of Pediatric Gastroenterology and Nutrition and Pediatric Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact